Evaluated by: David B. Kaminsky, M.D., FIAC, January 18, 2018
Original release date: January 18, 2018
Access to this course expires on: December 4, 2020, at 11:59 PM Pacific Time
The diagnosis of soft tissue and bone tumors can be a significant challenge (even for experienced pathologists) because of their rarity, the broad morphological spectrum of mesenchymal tumors, and overlap with other soft tissue tumors and non-mesenchymal neoplasms. The discovery of specific immunohistochemical markers and molecular genetic alterations drives the evolution of soft tissue tumor classification. If you are a surgical pathologist who struggles with accurate diagnosis of these challenging neoplasms, this is the course for you! Learn from experts in an environment that simulates clinical sign out.
Target AudiencePracticing academic and community pathologists, and pathologists-in-training
Learning Objectives Upon completion of this educational activity, learners will be able to:
Continuing Medical Education and Maintenance of Certification The United States and Canadian Academy of Pathology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The United States and Canadian Academy of Pathology designates this enduring material for a maximum of 11.5 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
USCAP is approved by the American Board of Pathology (ABPath) to offer Self-Assessment credits (SAMs) and Lifelong Learning (Part II) credit for the purpose of meeting the ABPath requirements for Continuing Certification (CC). Registrants must take and pass the post-test in order to claim SAMs credit.
Physicians can earn a maximum of 11.5 SAM/Part II credit hours.
Disclosures The faculty, committee members, and staff who are in position to control the content of this activity are required to disclose to USCAP and to learners any relevant financial relationship(s) of the individual or spouse/partner that have occurred within the last 12 months with any commercial interest(s) whose products or services are related to the CME content. USCAP has reviewed all disclosures and resolved or managed all identified conflicts of interest, as applicable.
The following faculty and coordinators reported no relevant financial relationships: Jason L. Hornick, M.D., Ph.D., Elizabeth G. Demicco, M.D., Ph.D., Brendan C. Dickson, M.D., MSc, G. Petur Nielsen, M.D.
USCAP staff associated with the development of content for this activity reported no relevant financial relationships.
To earn CME and SAM credit, all learners must take a content-based exam and achieve a minimum score of 80%. If learners do not achieve a passing score of 80%, they have the option to retake the exam. After you pass the test and complete the evaluation, your certificate of completion will be available to view and print by clicking here.
Buy the entire Diagnostic Challenges in Soft Tissue and Bone Pathology course and get a great discount!
Not A Member? Click Here